Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
Founded in 2011, Elicio Therapeutics Inc. ELTX has made several significant strides in the last 13 years. The immunotherapy company has completed multiple successful preclinical trials and has been featured in publications like Nature Medicine and Cancer Immunology Research, a journal of the…#eliciotherapeutics #amp #eli002 #kras #cpg #grandviewresearch #trialinprogress #amplify7p #eli0027p #pdac (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news

AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
TUESDAY, April 9, 2024 -- The novel viral-based personalized cancer vaccine, TG4050, which encodes up to 30 patient- and tumor-specific sequences is feasible and safe for patients with resected head and neck squamous cell carcinoma, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news

Moderna ’s (NASDAQ:MRNA) Latest Cancer Treatment Gives Shares New Life
For a while, things weren’t looking all that great for biotech stock Moderna (NASDAQ:MRNA). Its primary stock in trade, the COVID-19 vaccine, has b... (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news

Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early Trial
TUESDAY, April 9, 2024 -- A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.The vaccine could help liver cancer patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 9, 2024 Category: General Medicine Source Type: news

Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
MONDAY, April 8, 2024 -- A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.Eight patients have not had their pancreatic cancer recur... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in …
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell responses up to three years and delayed tumor recurrence in patients with resected pancreatic ductal…#phase1 #bnt122 #pdac #phase2 #autogene #genentechinc #genentech #rochegroup #inest #bntx (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Geneos cancer vaccine shrinks liver tumors in small trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday. The result was roughly twice the response typically seen…#geneostherapeutics #sandiego #naturemedicine #merckandco #markyarchoan #merck #keytruda #yarchoan #rna #geneos (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news

Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 7, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news

Theralase Secures Patent for Cancer Vaccine
Theralase Technologies (TSE:TLT) has released an update. Theralase Technologies Inc. has been awarded a Canadian patent for an innovative cancer va...#tse #tlt (Source: Reuters: Health)
Source: Reuters: Health - April 5, 2024 Category: Consumer Health News Source Type: news

Liberia: WHO and MOH Launch Hpv Vaccine Awareness
[New Dawn] The World Health Organization, in collaboration with the Ministry of Health of Liberia, has launched an awareness campaign on HPV Vaccine for Cervical Cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 2, 2024 Category: African Health Tags: Health and Medicine Liberia West Africa Source Type: news

Lung Cancer Vaccine Gets Injection of Funding for R & D Lung Cancer Vaccine Gets Injection of Funding for R & D
Researchers are using technology similar to that of COVID-19 vaccine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 2, 2024 Category: Consumer Health News Tags: Pulmonary Medicine Source Type: news

ASCO Releases Vaccination Guidelines for Adults With Cancer ASCO Releases Vaccination Guidelines for Adults With Cancer
A recent ASCO guideline provides recommendations for routine and additional vaccinations for adults with solid tumors or hematologic malignancies as well as their household contacts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Why Are So Many Young People Getting Cancer? It ’s Complicated
Just this month, two young, high-profile public figures announced that they have cancer. First, Olivia Munn, 43, disclosed that she was treated for breast cancer after catching it early. Days later, Kate Middleton, 42, announced she has been receiving treatment for an unspecified form of cancer. [time-brightcove not-tgx=”true”] Their diagnoses spotlight a troubling trend: both in the U.S. and around the world, cancer diagnoses are growing more common among adults younger than 50. By 2030, one recent study estimated, the number of these early-onset cancer diagnoses could increase by roughly 30% worldwide&md...
Source: TIME: Health - March 26, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news

Study Shows Elimination of Cervical Cancer With Vaccination Study Shows Elimination of Cervical Cancer With Vaccination
Dr Maurie Markman discusses results demonstrating the elimination of cervical cancer following vaccination in a population-based study.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Advances in Breast Cancer Treatment; Stroke After COVID Vaccination
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 24, 2024 Category: Hematology Source Type: news